SCHEMBL24590700

SCHEMBL24590700

CONc1ccc(N2CCN(Cc3cccc(C(=O)NCC(=O)c4ccccc4)c3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.60
▸ LMNA P02545 3/20 0.60
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MAPK1 P28482 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ HPGD P15428 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ DRD4 P21917 2/20 0.49
▸ HSD17B10 Q99714 4/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ USP2 O75604 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ ESR2 Q92731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23014167 0.83 POLB (0.61) MAPTLMNASMN1; SMN2L3MBTL1HTT
SCHEMBL23014364 0.82 DRD2 (0.66) DRD4POLB
SCHEMBL23014160 0.81 CHRM3 (0.61) LMNASMN1; SMN2L3MBTL1MAPK1TSHR
SCHEMBL23014343 0.79 ALDH1A1 (0.60) MAPTSMN1; SMN2MAPK1HPGDHTT
SCHEMBL23014286 0.79 HTR1A (0.55) TSHRHTTDRD4HSD17B10KMT2A
SCHEMBL23014309 0.78 CACNA1G (0.52) SMN1; SMN2L3MBTL1MAPK1TSHRHPGD
SCHEMBL23014151 0.77 ALDH1A1 (0.56) MAPTLMNASMN1; SMN2MAPK1TSHR
SCHEMBL27040179 0.77 HTR7 (0.62) MAPTLMNASMN1; SMN2L3MBTL1TSHR
SCHEMBL23014291 0.77 KDM4E (0.52) MAPTLMNASMN1; SMN2L3MBTL1MAPK1
SCHEMBL29733707 0.77 KDM4E (0.52) MAPTLMNASMN1; SMN2L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 — — EP disclosed
Send feedback